This Fund Manager Rating is based on the Citywire Long Only ratings methodology
Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated
About Erin Xie
Erin Xie, PhD, managing director, is a member of the Fundamental Equity division of BlackRock's Alpha Strategies Group. She is a member of BlackRock's Global Opportunities team. Erin is the team's lead portfolio manager for the healthcare sector, product manager for Health Sciences equity portfolios and a member of the team's Investment Strategy Group. Her service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, Erin was a senior vice president and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, she was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, Erin was a post-doctoral research scientist at Columbia University. She earned a BSc in Chemistry from Beijing University in 1988, a PhD in Biochemistry from the University of California, Los Angeles, in 1993 and an MBA from the Massachusetts Institute of Technology Sloan School of Management in 1999.
Citywire Rating: A rated
|7||Rudi Van den Eynde||7.6%|
|View full league table|
Month by Month Performance